ImmunityBio IBRX
NASDAQ IBRX
$8.31 -0.33 (-3.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Amortization of Deferred Charges (2022 - 2024)

Updated

Analysis

ImmunityBio (IBRX) Amortization of Deferred Charges (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,139.85 Bn 1,108.44 Bn 19.71 Bn
2 Johnson & Johnson 634.68 Bn 554.54 Bn 17.30 Bn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn
4 Merck 354.57 Bn 308.95 Bn 12.21 Bn
5 Novartis Ag 300.14 Bn 264.13 Bn 11.24 Bn
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn
7 Amgen 237.91 Bn 193.31 Bn 7.24 Bn
8 Gilead Sciences 193.96 Bn 168.15 Bn 6.22 Bn
9 Pfizer 170.07 Bn 116.71 Bn 10.94 Bn
10 ImmunityBio 8.58 Bn 7.35 Bn 50.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.01 Mn
Sep 30, 2024 6.20 Mn
Jun 30, 2024 5.83 Mn
Mar 31, 2024 5.55 Mn
Dec 31, 2023 7.12 Mn
Sep 30, 2023 11.45 Mn
Jun 30, 2023 12.29 Mn
Mar 31, 2023 11.54 Mn
Dec 31, 2022 11.04 Mn
Sep 30, 2022 4.50 Mn
Jun 30, 2022 374,000.00
Mar 31, 2022 370,000.00
API Access

ImmunityBio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IBRX&period=max&api_key=YOUR_API_KEY